Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes.
Reports suggest that troglitazone, and to a lesser extent bosentan, may alter bile acid homeostasis by inhibiting the bile salt export pump. The present studies examined the hypothesis that these xenobiotics may modulate multiple hepatic bile acid transport mechanisms. In suspended rat hepatocytes, troglitazone (10 microM) decreased the initial rate of taurocholate uptake approximately 3-fold; the initial uptake rate of estradiol-17beta-D-glucuronide, a substrate of the organic anion transporting polypeptides, also was decreased approximately 4-fold. Bosentan (100 microM) decreased the initial uptake rate of taurocholate and estradiol-17beta-D-glucuronide by approximately 12- and approximately 7-fold, respectively. In sandwich-cultured rat hepatocytes, 10-min accumulation of taurocholate in cells + bile canaliculi (408 +/- 57 pmol/mg protein) was decreased significantly by troglitazone (157 +/- 17 pmol/mg protein, respectively) only in the presence of Na+, the driving force for the sodium taurocholate cotransporting polypeptide. A similar decrease with 10-fold higher concentrations of bosentan was noted. The biliary excretion index of taurocholate (55 +/- 8%) was decreased in the presence of 10 microM troglitazone (27 +/- 2%) and 100 microM bosentan (10 +/- 6%). In conclusion, xenobiotics may alter hepatic bile acid transport by inhibiting both hepatic uptake and biliary excretion.
Kemp
Daniel C
DC
Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Zamek-Gliszczynski
Maciej J
MJ
Brouwer
Kim L R
KL
D000818:Animals; D001648:Bile Canaliculi / Q000187:drug effects* / Q000378:metabolism; D000077300:Bosentan; D002317:Cardiovascular Agents / Q000633:toxicity*; D002478:Cells, Cultured; D002839:Chromans / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D022781:Hepatocytes / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013449:Sulfonamides / Q000633:toxicity*; D013656:Taurocholic Acid / Q000493:pharmacokinetics*; D045162:Thiazolidinediones / Q000633:toxicity*; D000077288:Troglitazone
D002317:Cardiovascular Agents; D002839:Chromans; D004338:Drug Combinations; D013449:Sulfonamides; D045162:Thiazolidinediones; D013656:Taurocholic Acid; D000077288:Troglitazone; D000077300:Bosentan